Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Epistaxis
ADR ID BADD_A01528
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.03      Nasal disorders NEC
22.04.03.001      Epistaxis
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.01      Haemorrhages NEC
24.07.01.005      Epistaxis
Description A disorder characterized by bleeding from the nose. [CTCAE] Bleeding from the nose. [MeSH]
MedDRA Code 10015090
MeSH ID D004844
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bleeding nose | Epistaxis | Haemorrhage nasal | Hemorrhage nasal | Nasal bleeding | Nasal mucus blood tinged | Nose bleed | Nose bleeds | Nosebleed | Chronic epistaxis | Blood clot in nose | Nasal Bleeding | Bleeding, Nasal | Bleedings, Nasal | Nasal Bleedings | Nose Bleed | Nose Bleeds | Nosebleeds
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01978Ruxolitinib0.005380%
BADD_D01980Salicylic acid--
BADD_D01981Salmeterol--
BADD_D01984Samarium--
BADD_D01985Samarium sm-153 lexidronam--
BADD_D01986Samarium sm-153 lexidronam pentasodium--
BADD_D01989Saquinavir mesylate--
BADD_D01990Sargramostim--
BADD_D02002Selegiline--
BADD_D02006Selexipag0.000526%
BADD_D02010Sertraline0.000315%
BADD_D02011Sertraline hydrochloride--
BADD_D02016Sibutramine--
BADD_D02017Sibutramine hydrochloride--
BADD_D02018Sildenafil--
BADD_D02019Sildenafil citrate--
BADD_D02028Sirolimus--
BADD_D02031Sitaxentan--
BADD_D02058Sorafenib0.004007%
BADD_D02062Sparfloxacin--
BADD_D02097Sulindac--
BADD_D02098Sumatriptan--
BADD_D02100Sunitinib0.011294%
BADD_D02101Sunitinib malate--
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus--
BADD_D02106Tadalafil0.002108%
BADD_D02113Tamsulosin--
BADD_D02147Telmisartan--
BADD_D02151Temsirolimus--
The 16th Page    First    Pre   16 17 18 19 20    Next   Last    Total 20 Pages